Research ArticleOriginal Research

Examining the Effects of Formal Education Level on the Montreal Cognitive Assessment

Renee S. White, Justin M. Barber, Jordan P. Harp and Gregory A. Jicha
The Journal of the American Board of Family Medicine September 2022, jabfm.2022.AP.220093; DOI: https://doi.org/10.3122/jabfm.2022.AP.220093

References

  1. 1.↵
    1. Nasreddine ZS,
    2. Phillips NA,
    3. Bédirian V,
    4. et al
    . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–9.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Cordell CB,
    2. Borson S,
    3. Boustani M
    . Medicare Detection of Cognitive Impairment Workgroupet al. Alzheimer's association recommendations for operationalizing the detection of cognitive impairment during the Medicare annual wellness visit in a primary care setting. Alzheimers Dement 2013;9:141–50.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Lorentz WJ,
    2. Scanlan JM,
    3. Borson S
    . Brief screening tests for dementia. Can J Psychiatry 2002;47:723–33.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Luis CA,
    2. Keegan AP,
    3. Mullan M
    . Cross-validation of the Montreal Cognitive Assessment in community-dwelling older adults residing in the Southeastern US. Int J Geriatr Psychiatry 2009;24:197–201.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Bernstein IH,
    2. Lacritz L,
    3. Barlow CE,
    4. et al
    . Psychometric evaluation of the Montreal Cognitive Assessment (MoCA) in three diverse samples. Clin Neuropsychol 2011;25:119–26.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Rossetti HC,
    2. Lacritz LH,
    3. Cullum CM,
    4. Weiner MF
    . Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 2011;77:1272–5.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Hilgeman MM,
    2. Boozer EM,
    3. Snow AL,
    4. et al
    . Use of the Montreal Cognitive Assessment (MoCA) in a rural outreach program for military veterans. Journal of Rural Social Sciences 2019;34:2.
    OpenUrl
  8. 8.↵
    1. Dubois B,
    2. Padovani A,
    3. Scheltens P,
    4. et al
    . Timely diagnosis for Alzheimer’s disease: a literature review on benefits and challenges. J Alzheimers Dis 2016;49:617–31.
    OpenUrl
  9. 9.↵
    1. Ouellet M-C,
    2. Sirois M-J,
    3. Beaulieu-Bonneau S,
    4. et al
    . Correlates of cognitive functioning in independent elderly patients discharged home from the emergency department after a minor injury. Int Psychogeriat 2016;28:1313–22.
    OpenUrl
  10. 10.↵
    1. Rossetti HC,
    2. Lacritz LH,
    3. Hynan LS,
    4. et al
    .Montreal cognitive assessment performance among community-dwelling African Americans. Archives of Clinical Neuropsychology 2017;32:238–44.
    OpenUrl
  11. 11.↵
    1. Blair M,
    2. Coleman K,
    3. Jesso S,
    4. et al
    . Depressive symptoms negatively impact Montreal Cognitive Assessment performance: a memory clinic experience. Can J Neurol Sci 2016;43:513–7.
    OpenUrl
  12. 12.↵
    1. Langeard A,
    2. Pothier K,
    3. Morello R,
    4. et al
    . Polypharmacy cut-off for gait and cognitive impairments. Front Pharmacol 2016;7:296.
    OpenUrl
  13. 13.↵
    1. Dao E,
    2. Hsiung G-YR,
    3. Sossi V,
    4. et al
    . Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment. BMC Neurol 2015;15:197.
    OpenUrl
  14. 14.↵
    1. Liu W,
    2. Wong A,
    3. Au L,
    4. et al
    . Influence of amyloid-β on cognitive decline after stroke/transient ischemic attack: three-year longitudinal study. Stroke 2015;46:3074–80.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Szcześniak D,
    2. Rymaszewska J,
    3. Zimny A,
    4. et al
    . Cerebral small vessel disease and other influential factors of cognitive impairment in the middle-aged: a long-term observational cohort PURE-MIND study in Poland. GeroScience 2021;43:279–17.
    OpenUrl
  16. 16.↵
    1. Jiao F,
    2. Yi F,
    3. Wang Y,
    4. et al
    . The validation of multifactor model of plasma Aβ42 and total-tau in combination with MoCA for diagnosing probable Alzheimer disease. Front Aging Neurosci 2020;12:212.
    OpenUrl
  17. 17.↵
    1. Caldwell JZ,
    2. Berg J-L,
    3. Cummings JL,
    4. et al
    . Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume. Alzheimer’s Res Ther 2017;9:72.
    OpenUrlCrossRef
  18. 18.↵
    1. LaRose M,
    2. Aschenbrenner AJ,
    3. Benzinger TL,
    4. et al
    . A comparison of the Montreal Cognitive Assessment and standard cognitive measures in the National Alzheimer’s Coordinating Center and Knight Alzheimer’s Disease Research Center cohorts: Neuropsychology/early detection of cognitive decline with neuropsychological tests. Alzheimer’s & Dementia 2020;16:e046780.
    OpenUrl
  19. 19.↵
    1. Lee J-Y,
    2. Lee DW,
    3. Cho S-J,
    4. et al
    . Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. Journal of Geriatric Psychiatry and Neurology 2008;21:104–10.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.
    1. Freitas S,
    2. Prieto G,
    3. Simões MR,
    4. Santana I
    . Psychometric properties of the Montreal Cognitive Assessment (MoCA): an analysis using the Rasch model. Clin Neuropsychol 2014;28:65–83.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Gómez F,
    2. Zunzunegui M,
    3. Lord C,
    4. Alvarado B,
    5. García A
    . Applicability of the MoCA‐S test in populations with little education in Colombia. Int J Geriatr Psychiatry 2013;28:813–20.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Mueller SG,
    2. Weiner MW,
    3. Thal LJ,
    4. et al
    . The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am 2005;15:869–77.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.
    1. Beckett LA,
    2. Donohue MC,
    3. Wang C,
    4. et al
    . The Alzheimer's disease neuroimaging initiative phase 2: increasing the length, breadth, and depth of our understanding. Alzheimer’s Dement 2015;11:823–31.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Weiner MW,
    2. Veitch DP,
    3. Aisen PS,
    4. et al
    . The Alzheimer's disease neuroimaging initiative 3: continued innovation for clinical trial improvement. Alzheimer’s Dement 2017;13:561–71.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Besser L,
    2. Kukull W,
    3. Knopman DS,
    4. et al
    . Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set. Alzheimer Dis Assoc Disord 2018;32:351–8.
    OpenUrl
  26. 26.↵
    1. Weintraub S,
    2. Besser L,
    3. Dodge HH,
    4. et al
    . Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 2018;32:10–7.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Sheikh JI,
    2. Yesavage JA
    . Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clinical Gerontologist: The Journal of Aging and Mental Health 1986;5:(1–2), 165–173
    OpenUrlCrossRef
  28. 28.↵
    1. Donohue MC,
    2. Sperling RA,
    3. Salmon DP,
    4. et al
    . The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol 2014;71:961–70.
    OpenUrl
  29. 29.↵
    1. Morris JL,
    2. Hu L,
    3. Hunsaker A,
    4. et al
    . Patients’ and family members’ subjective experiences of a diagnostic evaluation of mild cognitive impairment. J Patient Exp 2020;7:124–31.
    OpenUrl
  30. 30.↵
    1. Gaugler JE,
    2. Ascher-Svanum H,
    3. Roth DL,
    4. et al
    . Characteristics of patients misdiagnosed with Alzheimer’s disease and their medication use: an analysis of the NACC-UDS database. BMC Geriatr 2013;13:137–10.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Tombaugh TN,
    2. Kozak J,
    3. Rees L
    . Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999;14:167–77.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Fernaeus S-E,
    2. Almkvist O,
    3. Bronge L,
    4. et al
    . White matter lesions impair initiation of FAS flow. Dement Geriatr Cogn Disord 2001;12:52–6.
    OpenUrlPubMed
  33. 33.↵
    1. Chertkow H,
    2. Nasreddine Z,
    3. Johns E,
    4. et al
    . P1‐143: The Montreal cognitive assessment (MoCA): Validation of alternate forms and new recommendations for education corrections. Alzheimer’s & Dementia 2011;7:S157–S157.
    OpenUrl
  34. 34.↵
    1. Franzen S,
    2. van den Berg E,
    3. Goudsmit M,
    4. et al
    . A systematic review of neuropsychological tests for the assessment of dementia in non-western, low-educated or illiterate populations. J Int Neuropsychol Soc 2020;26:331–51.
    OpenUrl
  35. 35.↵
    1. Julayanont P,
    2. Tangwongchai S,
    3. Hemrungrojn S,
    4. et al
    . The Montreal Cognitive Assessment—basic: a screening tool for mild cognitive impairment in illiterate and low‐educated elderly adults. J Am Geriatr Soc 2015;63:2550–4.
    OpenUrlPubMed
  36. 36.↵
    1. Cecato JF,
    2. Martinelli JE,
    3. Izbicki R,
    4. et al
    . A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease? Int Psychogeriatr 2016;28:825–32.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Fengler S,
    2. Kessler J,
    3. Timmermann L,
    4. et al
    . Screening for cognitive impairment in Parkinson's disease: improving the diagnostic utility of the MoCA through subtest weighting. PloS One 2016;11:e0159318.
    OpenUrl
  38. 38.↵
    1. Bocti C,
    2. Legault V,
    3. Leblanc N,
    4. et al
    . Vascular cognitive impairment: most useful subtests of the Montreal Cognitive Assessment in minor stroke and transient ischemic attack. Dement Geriatr Cogn Disord 2013;36:154–62.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Carvalho JO,
    2. Tommet D,
    3. Crane PK,
    4. et al
    . Deconstructing racial differences: The effects of quality of education and cerebrovascular risk factors. GERONB 2015;70:545–56.
    OpenUrl
  40. 40.↵
    1. Milani SA,
    2. Marsiske M,
    3. Cottler LB,
    4. et al
    . Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity. Alzheimer’s Dement 2018;10:773–81.
    OpenUrlPubMed
  41. 41.↵
    1. Sisco S,
    2. Gross AL,
    3. Shih RA,
    4. et al
    . The role of early-life educational quality and literacy in explaining racial disparities in cognition in late life. J Gerontol B Psychol Sci Soc Sci 2015;70:557–67.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords